Kennedy Capital Management LLC Buys 317,900 Shares of AdaptHealth Corp. $AHCO

Kennedy Capital Management LLC raised its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 15.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,408,038 shares of the company’s stock after acquiring an additional 317,900 shares during the quarter. Kennedy Capital Management LLC’s holdings in AdaptHealth were worth $23,984,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of AdaptHealth by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock worth $656,000 after purchasing an additional 2,564 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of AdaptHealth by 32.4% during the first quarter. Goldman Sachs Group Inc. now owns 571,232 shares of the company’s stock worth $6,192,000 after purchasing an additional 139,828 shares during the period. Woodline Partners LP bought a new position in shares of AdaptHealth during the first quarter worth approximately $2,851,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of AdaptHealth by 18.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock worth $2,534,000 after purchasing an additional 35,879 shares during the period. Finally, JPMorgan Chase & Co. increased its holdings in shares of AdaptHealth by 1.3% during the second quarter. JPMorgan Chase & Co. now owns 211,769 shares of the company’s stock worth $1,997,000 after purchasing an additional 2,718 shares during the period. 82.67% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction on Monday, June 1st. The shares were sold at an average price of $10.06, for a total transaction of $113,426.50. Following the transaction, the insider owned 136,538 shares in the company, valued at approximately $1,373,572.28. The trade was a 7.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Richard M. Cashin, Jr. bought 447,100 shares of the stock in a transaction that occurred on Friday, March 20th. The shares were purchased at an average cost of $9.91 per share, with a total value of $4,430,761.00. Following the purchase, the insider directly owned 16,312,698 shares of the company’s stock, valued at $161,658,837.18. The trade was a 2.82% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.95% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Jefferies Financial Group reaffirmed a “hold” rating and set a $11.00 target price on shares of AdaptHealth in a report on Monday, April 20th. Wall Street Zen raised shares of AdaptHealth from a “hold” rating to a “buy” rating in a report on Sunday. Royal Bank Of Canada raised their target price on shares of AdaptHealth from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Monday, May 11th. Canaccord Genuity Group raised their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, AdaptHealth presently has an average rating of “Moderate Buy” and an average price target of $14.29.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $10.16 on Friday. AdaptHealth Corp. has a fifty-two week low of $8.06 and a fifty-two week high of $13.43. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71. The firm has a market capitalization of $1.38 billion, a P/E ratio of -16.39, a P/E/G ratio of 0.52 and a beta of 1.47. The company’s 50 day moving average price is $11.34 and its two-hundred day moving average price is $10.57.

AdaptHealth (NASDAQ:AHCO) last issued its earnings results on Tuesday, May 5th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.13). AdaptHealth had a negative net margin of 2.42% and a positive return on equity of 2.76%. The company had revenue of $819.80 million during the quarter, compared to analyst estimates of $796.63 million. During the same quarter in the prior year, the business earned ($0.05) EPS. The business’s quarterly revenue was up 5.4% on a year-over-year basis. On average, equities analysts forecast that AdaptHealth Corp. will post 0.44 earnings per share for the current fiscal year.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.